Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $408.0700 (3.01%) ($394.2000 - $410.4900) on Tue. Apr. 12, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.14% (three month average) | RSI | 61 | Latest Price | $408.0700(3.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 5.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(63%) XLV(51%) XBI(47%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.57% in a week (0% probabilities). VIXM(-11%) UUP(-8%) TLT(-8%) IPO(-5%) SHY(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.57% (StdDev 3.14%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
5 Day Moving Average | $410.97(-0.71%) | 10 Day Moving Average | $399.74(2.08%) | 20 Day Moving Average | $384.63(6.09%) | To recent high | -15.5% | To recent low | 13.5% | Market Cap | $43.267b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |